Document is current

Any future updates will be listed below

Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial

Crossref DOI link: https://doi.org/10.1136/jitc-2022-004952

Published Online: 2022-12-06

Published Print: 2022-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark